Cancer Cell International

Article	Citations
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia	412
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma	277
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules	241
miR-196a-5p promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting LIFR	223
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	176
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	137
Shared molecular mechanisms of common differentially expressed genes (C-DEGs) linking gallbladder stones to carcinogenesis: integrated bioinformatics and experimental validation	125
CDK4 inhibition by luteolin enhances lenvatinib sensitivity in HCC via Wnt/β-catenin modulation	117
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	106
SETDB1 promotes gastric cancer progression via UPR and mTOR pathway	106
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer	99
Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects	97
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma	91
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7	86
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	86
Human amniotic epithelial cells exert anti-cancer effects through secretion of immunomodulatory small extracellular vesicles (sEV)	83
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	81
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	81
Transcription factor MYB regulates glycolysis to promote the transfer and malignant progression of gastric cancer through the SSBP2/ISL1 axis	80
Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC	79
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	78
Melanoma biology and treatment: a review of novel regulated cell death-based approaches	77
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	74
Cuproptosis: a promising new target for breast cancer therapy	72
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers	72

New models for MPNST: establishment and comprehensive characterization of two tumor cell lines	70
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	68
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	65
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells	63
Targeting the CCL5/CCR5-PI3K-AKT axis suppresses hepatic stellate cell-induced breast cancer metastasis	62
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	62
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways	60
ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR	59
Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein	58
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells	57
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics	57
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	56
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	56
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	55
TAGLN: a stiffness-driven prognostic biomarker for metastatic colorectal cancer	54
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	53
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	53
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer	53
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma	53
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing	52
Etiology of polyploid giant cancer cells: a new frontier in cancer biology	52
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	51
Molecular mechanisms of microRNA-216a during tumor progression	50
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	50
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	50
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors	49
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway	49
Hepatocellular carcinoma drug resistance models	48
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC	48
Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma	46
Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis	45
[email protected] nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor	45
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis	45
Identification of CD4_Naive cells related gene FMO4 as a positive regulator of the poor prognosis of septic CRC patients	45
Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness	45
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia	45
Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model	44
Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation	44
C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer	44
Oncogenic roles of the lncRNA LINC00460 in human cancers	43
Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer	43
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing	43
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma	42
Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy	42
ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer	41
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy	40
Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma	40
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	39
G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells	39
STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment	39

The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma	38
Development of a G2/M checkpoint subtype classifier for guiding precision therapy in liver hepatocellular carcinoma patients	37
Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease	37
Microglia-mediated drug substance transfer promotes chemoresistance in brain tumors: insights from an in vitro co-culture model using GCV/Tk prodrug system	37
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer	37
Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China	37
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes	37
Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy	36
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1	36
Spatial and single-cell analyses uncover links between ALKBH1 and tumor-associated macrophages in gastric cancer	36
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis	36
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment	35
The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis	35
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis	35
Divergent effects of topical deferoxamine treatment on skin and cancer cells uncovers its potential as a safe radioprotective agent in oncological applications	34
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma	34
Predicting survival of persons with newly-diagnosed multiple myeloma	33
The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications	33
Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic	33
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model	33
CAR-T cell combination therapy: the next revolution in cancer treatment	33
Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population	33
Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma	33
Deapioplatycodin D inhibits glioblastoma cell proliferation by inducing BNIP3L-mediated incomplete mitophagy	33
Luteolin: a flavonoid with a multifaceted anticancer potential	32
Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis	32
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review	32
PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway	32
Dysregulation of ferroptosis-related genes and the ACSL4-mediated ferroptosis-PD-L1 axis in prostate cancer pathogenesis	32
Construction of anti-tumor immune gene signature for HNSCC and identification of 4'-Hydroxywogonin as a potential immunotherapy combination drug	32
Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies	32
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC	32
Ferroptosis: insight into the treatment of hepatocellular carcinoma	31
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility	31
Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer	31
Circular RNA circPTPRF promotes the progression of GBM via sponging miR-1208 to up-regulate YY1	31
Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer	31
SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype	31
Retraction Note: MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression	30
Retraction Note: LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146	30
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms	30
Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy	29
Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis	29
Personalized chemotherapy guided by drug sensitivity of circulating tumor cells improves outcomes in advanced biliary tract cancer	29
Exploring the oncogenic mechanism of plasmacytoma variant translocation 1 (PVT1) gene in solid cancers; emphasis on microRNA regulation pathways	29
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads	28
Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study	28
Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway	28
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells	28
Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy	28
The upregulation of VGF enhances the progression of oral squamous carcinoma	27
Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma	27
E3 ubiquitin ligase HECW2: a promising target for tumour therapy	27
The impact of gut bacteria producing long chain homologs of vitamin K2 on colorectal carcinogenesis	27
The role of LncRNAs in tumor immunotherapy	27
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential	27
Migration and invasion of cancer stem cells are prevented by low-intensity pulsed ultrasound therapy	27
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma	27
Interaction of AURKA with TRIM28 revives dormant LSCC cells via Akt signaling pathway to promote LSCC metastasis	26
Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression	25
circ_0061265 competitively binds to microRNA-885-3p to promote the development of gastric cancer by upregulating AURKA expression	25
The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor	25
Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma	25
Salivary genetic biomarkers of lung cancer: a systematic review and meta-analysis of the diagnostic accuracy	25
Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma	25
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF	25
Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer	25
Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways	25
Novel insights into the interaction between IGF2BPs and ncRNAs in cancers	25
Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy	25
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human gliob	24
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B	24
TGFBI deficiency facilitates tumor associated macrophages M2 polarization and angiogenesis to promote pancreatic neuroendocrine neoplasms progression	24
NSC777201 exhibits anticancer activity against colorectal cancer cells by inducing multiple types of cell death	24
PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function	24
The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression	24
Retraction Note: Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis	24
Correction: TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma	24
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	24
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling	24

Helicobacter pylori promotes gastric cancer progression via UPP1-mediated uridine bypass of glycolysis	23
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation	23
Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells	23
RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway	23
Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitro	23
miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling	23
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma	23
Retraction Note: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma	23
Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells	23
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?	23
Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers	22
A review on the role of mir-16-5p in the carcinogenesis	22
Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma	22
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects	22
Identification and validation of a prognostic model based on three TLS-Related genes in oral squamous cell carcinoma	22
LTCONS_00014107-miR-29b-2-3p-GPR37 axis promotes heat stimulation induced esophageal carcinogenesis	22
Association of whole grain food consumption with lung cancer risk: a prospective cohort study	22
LncRNA SNHG1: role in tumorigenesis of multiple human cancers	22
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade	22
Novel a new prognostic model of thyroid carcinoma based on macrophage and cuproptosis-related lncRNA	21
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges	21
Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer	21
The role of m6A modification in non-small cell lung cancer: functional insights and impact on therapy resistance	21
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review	21
Environmental interpretation of the impact of vehicle emissions on prostate cancer progression	21
Invasiveness-related microRNA expression in glioma: associations with clinical outcomes, tumor burden, and health-related quality of life	21
Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis	21
Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer	21
Targeted suppression of DNA polymerase θ enhances calcium flux and triggers intrinsic apoptosis in gastric cancer	21
Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene	21
Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma	21
LncRNA SPINT1-AS1 enhances the Warburg effect and promotes the progression of osteosarcoma via the miR-135b-5p/PGAM1 axis	21
Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies	21
Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis	21
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients	21
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma	21
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression	21
Targeting oral tumor microenvironment for effective therapy	21
Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models	21
A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer	21
Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression	21
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care	20
Retraction Note: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription	20
Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1	20
MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells	20
Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing	20
An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer	20
Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors	20
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy	20
Prognostic evaluation and experimental validation of cuproptosis-related hub genes identified through weighted gene co-expression network analysis in uveal melanoma	20
8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1/miR-101-3p/SLC7A11 axis	20
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures	20
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma	20
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation	20
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression	20
Emerging roles for lncRNA-NEAT1 in colorectal cancer	19
Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?	19
Integrating multi-omics data revealing LIMK1 as a metastatic biomarker in LUAD patients with brain metastasis	19
Disruption of DMD gene leads to altered calcium homeostasis and metabolic shift impacting gastric Cancer cell proliferation and migration	19
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications	19
Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma	19
Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis	19
Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma	19
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies	19
MDM2: current research status and prospects of tumor treatment	19
Very long-chain fatty acids accumulate in breast cancer tissue and serum	19
Unraveling the oncogenic and immunomodulatory roles of GINS1: a systematic pan-cancer study	19
Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine	19
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma	19
Paris saponin VII suppresses osteosarcoma progression by targeting VEGFR2 and PD-L1 to enhance anti-angiogenic and immunotherapeutic efficacy	19
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review	19
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses	19
Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma	19
CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation	19
Transforming bone cancer treatment: a comprehensive review of green-synthesized metal nanoparticles	19
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells	19
Methylome profiling reveals context-dependent chemo-resistance mechanisms and enhances risk stratification in AML	19
LIS1 mediated Schwann cell reprogramming enhances perineural invasion by activating the serine/NMDAR/AKT signaling pathway in head and neck squamous carcinoma	19
Green-synthesized MnFe₂O₄/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy	19
Correction to: SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition	19
Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression	19
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1	19
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis	19
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma	19
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways	19
UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression	19
NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to represses malignant phenotype of non-small cell lung cancer cells	18
Inhibition of RBM23 induces ferroptosis in colon cancer cells via c-Myc regulation	18
Recent advances in the detection of glioblastoma, from imaging-based methods to proteomics and biosensors: A narrative review	18
Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer	18
Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer	18
Role of epithelial splicing regulatory protein 1 in cancer progression	18
Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy	18
MicroRNA-regulated signaling and tumor microenvironment modulation in lung cancer: mechanistic insights and translational opportunities	18
TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy	18